Use UniProt P25023 as the stable identity anchor, then attach disease evidence before program review.
CHEMBL2501 Target Snapshot
B2 bradykinin receptor · SINGLE PROTEIN · Rattus norvegicus
Research home keeps recent targets
This target will appear in recent viewed items on this browser. Use the demo workspace to preview watch rules and decision queues.
Switch target
Move to another high-traffic target or paste a specific ChEMBL target ID.
Frame the target before identity details
Structured disease, protein, and project context should read before the lower-level identity rail.
As of 2026-09-14Protein identity stays anchored to UniProt P25023. Use UniProt P25023 as the stable identity anchor, then attach disease evidence before program review.
B2 bradykinin receptor
Review this target as B2 bradykinin receptor, mapped to UniProt P25023. Sequence length is 396 aa.
Protein source · UniProt accession via ChEMBL component mappingCross-source identity
Keep the review anchor, source IDs, and context contract aligned before reusing this target elsewhere.
This review treats B2 bradykinin receptor as ChEMBL target CHEMBL2501, mapped to UniProt P25023. Disease framing currently uses the Open Targets-ready proxy contract.
Reuse the same identifiers in notes, watch rules, exports, and review packs so provenance stays stable across surfaces.
Start with the right source
Choose the first block or source based on the question you are trying to answer.
Start here when your first question is whether B2 bradykinin receptor is the right protein anchor across sources, using UniProt P25023 as the stable mapping.
Jump to Protein ContextUse this block first when you need the strongest disease program and evidence level in one place.
Jump to Disease ContextOpen the one-page evidence card when you want the rationale, activity base, and attribution together.
Open Review-ready CardBasic Information
Verify identity, organism, and the fastest next research jumps from the same page.
| Preferred Name | B2 bradykinin receptor |
| Target Type | SINGLE PROTEIN |
| Organism | Rattus norvegicus |
| UniProt | P25023 |
Next Actions
UniProt Target Context
Reviewable protein naming and mapping context for this target snapshot.
| Protein Label | B2 bradykinin receptor |
| UniProt Accession | P25023 |
| Component Type | Protein |
| Sequence Length | 396 aa |
B2 bradykinin receptor
How to read this target
Review this target as B2 bradykinin receptor, mapped to UniProt P25023. Sequence length is 396 aa.
Clinical Phase Distribution
Activity Type Distribution
Top Inhibitors (by pChEMBL)
| ChEMBL ID | pChEMBL | Type | Value (nM) | Phase |
|---|---|---|---|---|
| CHEMBL1907651 | 10.64 | Ki | 0.023 | Preclinical |
| CHEMBL2028850 | 10.11 | Ki | 0.077 | Approved |
| CHEMBL1907652 | 9.51 | Ki | 0.31 | Preclinical |
| CHEMBL2028850 | 9.5 | Kd | 0.3162 | Approved |
| CHEMBL406291 | 9.34 | Ki | 0.46 | Clinical |
| CHEMBL3038099 | 9.31 | Kd | 0.4898 | Preclinical |
| CHEMBL2112937 | 9.3 | Ki | 0.5 | Preclinical |
| CHEMBL308468 | 9.3 | Ki | 0.5 | Preclinical |
| CHEMBL2112044 | 9.22 | Ki | 0.6 | Preclinical |
| CHEMBL431562 | 9.22 | Ki | 0.6 | Preclinical |
pChEMBL Value Distribution
Approved Drugs
Assay Landscape
Binding — 8 assays, 27 compounds
| BAO Format | Assays | Compounds | Avg pChEMBL |
|---|---|---|---|
| cell membrane format | 3 | 23 | 7.6 |
| cell-based format | 2 | 3 | 9.2 |
| tissue-based format | 2 | 0 | — |
| assay format | 1 | 1 | 6.4 |
Functional — 4 assays, 19 compounds
| BAO Format | Assays | Compounds | Avg pChEMBL |
|---|---|---|---|
| tissue-based format | 3 | 17 | 8.0 |
| cell-based format | 1 | 2 | 6.9 |